Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model

In a head-to-head diet-induced obese (DIO) mouse study,ASC47 low dose combination 1 (ASC47,3 mg/kg,subcutaneous (SQ),once every four weeks plus semaglutide,30 nmol/kg,SQ,once daily),demonstrated super

12-19

Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production

SHANGHAI,Dec. 18,2024-- ShanghaiJuncell Therapeutics Co.,Ltd. (Juncell Therapeutics),a clinical-stage biotech focused on innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies,annou

12-19

China's First Factory-Based Seawater Hydrogen Production Project Completed at Sinopec Qingdao Refinery

QINGDAO,China,Dec. 19,2024-- China Petroleum & Chemical Corporation\'s (HKG: 0386,"Sinopec") completes China\'s first factory-based seawater hydrogen production research project at its

12-19

Gogoro Earns Frost & Sullivan's 2024 Global Company of the Year Award for Pioneering Sustainable Urban Mobility with Groundbreaking Battery-swapping Platform and Ecosystem

Gogoro\'s battery-swapping ecosystem revolutionized urban mobility by offering a sustainable,highly efficient,and customer-centric alternative to traditional electric vehicle charging.

12-19 Frost & Sullivan

Green Power as a Medium to Create a Zero-Carbon Tourism Model

BOLE,China,Dec. 18,2024--On December 17,the temperature atSayram Lake dropped sharply,causing ice waves to form along the edge of the water. Irregularly sized and shaped floating ice blocks collided w

12-19 State Grid Bortala Power Supply Company

Clarity expands its pipeline with a novel optimised FAP-targeted radiopharmaceutical

Highlights Clarity has developed a proprietary fibroblast activation protein (FAP)-targeted radiopharmaceutical product that can be used with the perfect pairing of copper isotopes for the diagnosis

12-19 Clarity Pharmaceuticals

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

LOS ANGELES,Dec. 19,2024-- Pharus Diagnostics LLC. (PharusDx),an innovator in non-invasive diagnostic tests,today announced a significant step forward in the fight against pancreatic cancer. The comp

12-19 Pharus Diagnostics

Hyundai Motor Group Secures Top Spot for Safety at 2024 IIHS Awards with the Most TSP and TSP+ Titles of any Auto Manufacturer

Hyundai Motor secures nine awards,Genesis earns eight,andKia receives five Hyundai is ranked second and Genesis is ranked third tied with Honda and Mazda,respectively,among global brands with the most

12-19 Hyundai Motor Group

Funding Societies secures investment from Cool Japan Fund

CJF\'s injection kicks off Funding Societies\' 10th year track record in serving SMEs in Southeast Asia

12-19 Funding Societies

Water Earth Token: Create a new era of clean water alliance and business services

12-19